Fertility drugs and ovarian cancer

References

• Heintz A. P., Hacker N. F., Lagasse L. D. Epidemiology and etiology of ovarian cancer: a review. Obstet. Gynecol. 1985; 66: 127–35
   PubMed Web of Science ®Google Scholar
• Di Saia P. J. Ovarian disorders. Danforth's Obstetrics and Gynecology, 6th edn., J. R. Scott, P. J. Di Saia, C. B. Hammond, W. N. Spellacy. J.B. Lippincott Co., Philadelphia 1990; 1067–120
   Google Scholar
• Trimble E. L. The NIH Consensus Conference on Ovarian Cancer: Screening, Treatment, and Follow-up. Gynecol. Oncol. 1994; 55: S1–S3
   Google Scholar
• Schenker J. G., Ezra Y. Complications of assisted reproductive techniques. Fertil. Steril. 1994; 61: 411–22
   PubMed Web of Science ®Google Scholar
• Montreuil J. Third National Cancer Survey: Incidence Data, Natl. Cancer Inst. Monogr., S.J. Cutler, J. L. Young. DHEW publication (NIH), Government Printing Office, Washington 1975; 41: 775–87
   Google Scholar
• Kolstad P., Beecham J. C. Epidemiology of ovarian neoplasia. Diagnosis and Treatment of Ovarian Neoplastic Alterations, de Watteville, et al. Excerpta Medica, Amsterdam 1975; 56–62
   Google Scholar
• Lingeman C. M. Etiology of cancer of the human ovary: a review. J. Natl. Cancer Inst. 1974; 53: 1603
   Google Scholar
• Parazzini F., Franceschi S., La Vecchia C., Fasoli M. The epidemiology of ovarian cancer. Gynecol. Oncol. 1991; 43: 9–23
   PubMed Web of Science ®Google Scholar
• Hartge P., Schiffman M. H., Hoover R., McGowan L., Lesher L., Norris H. J. A case-control study of epithelial ovarian cancer. Am. J. Obstet. Gynecol. 1989; 161: 10–166
   PubMed Web of Science ®Google Scholar
• Reyes F. I., Winter J. S. D., Failman C. Pituitary-ovarian relationships preceding the menopause. I. A cross selectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am. J. Obstet. Gynecol. 1977; 129: 557–64
   PubMed Web of Science ®Google Scholar
• Chakravarti S., Collins W. P., Forecast J. D., Newton J. R., Oram D. H., Studd J. W. W. Hormonal profiles after the menopause. Br. Med. J. 1976; 2: 784–6
   PubMed Web of Science ®Google Scholar
• Stadel B. V. The etiology and prevention of ovarian cancer. Am. J. Obstet. Gynecol. 1975; 123: 772–3
   PubMedGoogle Scholar
• Mohle J., Whittemore A. S., Pike M., Darby S., Cramer D. Letters to the Editor. J. Natl. Cancer Inst. 1985; 75: 178–80
   PubMedGoogle Scholar
• Booth M., Beral V., Smith P. Risk factors for ovarian cancer: a case control study. Br. J. Cancer 1989; 60: 592–8
   PubMed Web of Science ®Google Scholar
• Pike M. C., Chilvers C. Oral contraceptive and breast cancer. The current controversy. J. R. Soc. Health 1985; 105: 5–10
   Google Scholar
• Franceschi S. Reproductive factors and cancers of the breast, ovary and endometrium. Eur. J. Cancer Clin. Oncol. 1989; 25: 1933–43
   PubMedGoogle Scholar
• Ron E., Lunenfeld B., Menczer J., Blumstein T., Katz L., Oelsner G., Serr D. Cancer incidence in a cohort of infertile women. Am. J. Epidemiol. 1987; 125: 780–90
   PubMed Web of Science ®Google Scholar
• Cramer D. W., Hutchison G. B., Welch W. R., Scully R. E., Ryan K. J. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J. Natl. Cancer Inst. 1983; 71: 711–16
   PubMed Web of Science ®Google Scholar
• Nasca P. C., Greenwald P., Chorost S., Richart R., Caputo T. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am. J. Epidemiol. 1984; 119: 705–13
   Google Scholar
• La Vecchia C., Decarli A., Franceschi S., Regallo M., Tognoni G. Age at first birth and the risk of epithelial ovarian cancer. J. Natl. Cancer Inst. 1984; 73: 663–6
   Google Scholar
• McGowan L., Norris H.J., Hartge P., Hoover R., Lesher L. Risk factors in ovarian cancer. Eur. J. Gynaecol. Oncol. 1988; 9: 195–9
   Google Scholar
• Whittemore A. S., Harris R., Itnyre J., Halpern J., the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies I Methods. Am. J. Epidemiol. 1992; 136: 1175–83
   Google Scholar
• Whittemore A. S., Harris R., Itnyre J., the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am. J. Epidemiol 1992; 136: 1184–203
   PubMed Web of Science ®Google Scholar
• Harris R., Whittemore A. S., Itnyre J., the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Am. J. Epidemiol. 1992; 136: 1204–11
   PubMed Web of Science ®Google Scholar
• Whittemore A. S., Harris R., Itnyre J., the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Am. J. Epidemiol 1992; 136: 1212–20
   PubMed Web of Science ®Google Scholar
• Adami H. O., Hsieh C., Lambe M., Trichopoulos D., Leon D., Persson I., Ekbom A., Janson P. O. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994; 344: 1250–4
   PubMed Web of Science ®Google Scholar
• Taylor R. S., Carroll B. E., Lloyd J. W. Mortality among women in three catholic religious orders with special references to cancer. Cancer 1959; 12: 1207–25
   Google Scholar
• Fraumeni J. F., Lloyd J. W., Smith E. M., et al. Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in women. J. Natl. Cancer Inst. 1969; 42: 455–68
   PubMedGoogle Scholar
• Lund E. Mortality from ovarian cancer among women with many children. Int. J. Epidemiol. 1992; 21: 872–6
   Google Scholar
• Cramer D. W., Hutchison G. B., Welch W. R., Scully R. E., Knapp R. C. Factors affecting the association of oral contraceptives and ovarian cancer. N. Engl. J. Med. 1982; 307: 1047–51
   Google Scholar
• Rasmussen A. T. The weight of the principal components of the normal hypophysis cerebri of the adult human female. Am. J. Anat. 1934; 55: 253–75
   Google Scholar
• Balasch J., Barri P. N. Follicular stimulation and ovarian cancer?. Hum. Reprod. 1993; 8: 990–6
   PubMedGoogle Scholar
• Joly D. J., Lilenfield A. M., Diamond E. L. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am. J. Epidemiol 1974; 99: 190–209
   Google Scholar
• Bengtsson M., Hamberger L., Rydstrom J. Metabolism of 7,12-dimethylbenz(a)an-thracene by different types of cells in the human ovary. Xenobiotica 1988; 18: 1255–70
   Web of Science ®Google Scholar
• Cramer D. W., Welch W. R., Scully R. E., Wojciechowski C. A. Ovarian cancer and talc: a case-control study. Cancer 1982; 50: 372–6
   PubMed Web of Science ®Google Scholar
• Nikrui N. Survey of clinical behavior of patients with borderline epithelial tumors of the ovary. Gynecol. Oncol. 1985; 12: 107–1926
   Google Scholar
• Aure J. C., Hoeg K., Kolstad P. Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases. Obstet. Gynecol. 1971; 37: 1–9
   PubMedGoogle Scholar
• Julian C. G., Woodruff J. D. The biologic behavior of low grade papillary serous carcinoma of the ovary. Obstet. Gynecol. 1972; 40: 860–7
   PubMedGoogle Scholar
• Harlow B. L., Weiss N. S., Lofton S. Epidemiology of borderline ovarian tumors. J. Natl. Cancer Inst. 1987; 78: 71–4
   Google Scholar
• Scully R. E. Common epithelial tumors of borderline malignancy (carcinoma of low malignant potential). Bull. Cancer (Paris) 1982; 69: 228–38
   Google Scholar
• Colgan T.J., Norris H. J. Ovanan epithelial tumors of low malignant potential: a review. Int. J. Gynecol. Pathol. 1983; 1: 376–82
   Google Scholar
• Nicosia S., Nicosia R. Neoplasm of the ovanan mesothelium. Pathology of Human Neoplasm, H. Azar. Raven Press, New York 1988; 435–86
   Google Scholar
• Cramer D. W., Welch W. R. Determinants of ovarian cancer risk. II. Interferences regarding pathogenesis. J. Natl. Cancer Inst. 1983; 71: 717–21
   PubMedGoogle Scholar
• Gondos B. Surface epithelium of the developing ovary. Am. J. Pathol. 1975; 81: 303–12
   Google Scholar
• Vierikko P., Kauppilla A., Vihko R. Cytosol and nuclear estrogen and progesterone receptors and 17b˜-hydroxysteroid dehydrogenase activity in nondiseased tissue and in benign and malignant tumors of the human ovary. Int. J. Cancer 1983; 32: 413–22
   PubMed Web of Science ®Google Scholar
• Richman C. M., Holt J. A., Lorincz M. A., Herbst A. L. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy. Obstet. Gynecol. 1985; 65: 257–63
   Google Scholar
• Bizzi A., Codegoni A. M., Landoni F., Marelli G., Marsoni S., Spina A. M., Torri W., Mangioni C. Steroid receptors in epithelial ovanan carcinoma: relation to clinical parameters and survival. Cancer Res. 1988; 48: 6222–6
   PubMedGoogle Scholar
• Nash J. P., Ozols R. F., Smyth J. F., et al. Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro. Obstet. Gynecol. 1989; 73: 1009–16
   PubMedGoogle Scholar
• Friberg L. G., Kullander S., Persijn J. P., Korsten C. B. On receptors for estrogens (E2) and androgens (DHT) in human endometrial and ovanan tumors. Acta Obstet. Gynecol. Scand. 1978; 57: 261–4
   Web of Science ®Google Scholar
• Holt J. A., Caputo T. A., Kelly K. M., Greenwald P., Chorost S. Estrogen and progestin binding in cytosol of ovarian carcinoma. Obstet. Gynecol 1979; 53: 50–8
   Google Scholar
• Galli M. C., De Giovanni C., Nicoletti G., Grilli S., et al. The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovary. Cancer 1981; 47: 1297–302
   Google Scholar
• Nicosia S., Saunders B. Corpus luteum extract stimulates the growth of ovarian surface epithelial cells. Lab. Invest. 1986; 54: 47a
   Google Scholar
• Oka Y., Ortho D. Human plasma epidermal growth factor/b˜-urogastrone is associated with blood platelets. J. Clin. Invest. 1983; 72: 249–59
   PubMed Web of Science ®Google Scholar
• Davy M., Torjesen P. A., Aakvaag A. Demonstration of an FSH receptor in a functioning granulosa cell tumour. Acta Endocrinol. 1977; 85: 615–23
   Google Scholar
• Stouffer R. L., Grodin M. S., Davis J. R., Surwit E. A. Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers. J. Clin. Endocrinol. Metab. 1984; 59: 441–6
   PubMedGoogle Scholar
• Graves P. E., Surwit E. A., Davis J. R., Stouffer R. L. Adenylate cyclase in human ovarian cancer: sensitivity to gonadotropins and non hormonal activators. Am. J. Obstet. Gynecol. 1985; 153: 877–82
   PubMed Web of Science ®Google Scholar
• Nakano R., Kitayama S., Yamoto M., Shima K., Ooshima A. Localization of gonadotropin binding sites in human ovarian neoplasm. Am. J. Obstet. Gynecol. 1989; 161: 905–10
   PubMed Web of Science ®Google Scholar
• Schally A. V. The use of LH-RH analogs in gynecology and tumor therapy. Advances in Gynecology and Obstetrics: General Gynecology, P. Belfort, J. A. Pinotti, T. K. A. B. Eskes. Parthenon Publishing, Camforth, UK 1989; 6: 3–20
   Google Scholar
• Schally A. V. (1992) Luteinizing hormone-releasing hormone analogs in medicine. Fertility and Sterility: Progress in Research and Practice The Proceedings of the XIV World Congress on Fertility and Sterility Caracas Venezuela. 1992, O. Rodriguez-Armas. Parthenon Publishing, Camforth, UK, 233–61
   Google Scholar
• Schally A. V., Bajusz S., Redding D. W., Zalatnai A., Comaru-Schally A. M. Analogs of LH-RH: the present and the future. GnRH Analogues in Cancer and Human Reproduction, B. H. Vickery, B. Lunenfeld. Kluwer, Dordrecht 1989; 1: 5–31
   Google Scholar
• Emons G., Schally A. V. The use of luteinizing hormone-releasing hormone agonists and antagonists in gynaecological cancers. Hum. Reprod. Update 1994; 9: 1364–79
   Google Scholar
• Yano T., Pinski J., Radulovic S., Schally A. V. Inhibition of human epithelial ovarian cancer cell growthin vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA 1994; 91: 1701–5
   PubMed Web of Science ®Google Scholar
• Emons G., Ortmann O., Becker M., Irmer G., Springer B., Laun R., Hölzel F., Schulz K.-D., Schally A. V. High affinity binding and direct antiproliferative effects of LH-RH analogues in human ovarian cancer cell lines. Cancer Res. 1993; 54: 5439–46
   Google Scholar
• Klingmuller D., Schepke M., Enzweiler C., Bidlingmaier F. Hormonal responses to the new potent GnRH antagonist Cetrorelix. Acta Endocrinol. 1993; 128: 15–18
   PubMedGoogle Scholar
• Manetta A., Gamboa-Vujicic G., Paredes P., Emma D., Liao S., Leong L., Asch B., Schally A. Inhibition of growth of human ovarian cancer in nude mice by luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75). Fertil. Steril. 1995; 63: 282–7
   Google Scholar
• Fathalla M. F. Incessant ovulation - a factor in ovarian neoplasia?. Lancet 1971; 2: 163
   PubMed Web of Science ®Google Scholar
• Lowry S., Russel H., Hickey I., Atkinson R. Incessant ovulation and ovarian cancer. Lancet 1991; 337: 1544–5
   PubMedGoogle Scholar
• Casagrande J. T., Pike M. C., Ross R. K., Louie E. W., Roy S., Henderson B. E. 'Incessant ovulation' and ovarian cancer. Lancet 1979; 2: 170–3
   PubMed Web of Science ®Google Scholar
• Fishel S., Jackson P. Follicular stimulation for high tech pregnancies: are we playing it safe?. Br. Med. J. 1989; 299: 309–11
   PubMedGoogle Scholar
• Tarlatzis B. C., Grimbizis G., Bonds J., Mantalenakis S. Ovarian stimulation and ovarian tumours: a critical reappraisal. Hum. Reprod. Update 1995; 1: 284–301
   Google Scholar
• Goldberg G. L., Runowicz C. D. Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation - is there a link?. Am. Obstet. Gynecol. 1992; 166: 853–4
   PubMed Web of Science ®Google Scholar
• Burger C. W., Nijman H. W., Baak J. P. A., Schats R., Vermarken J. B., Schoemaker J., Kenemans P. Borderline tumor of the ovary (BTO) and controlled hyperstimulation, a report of two cases. Hum. Reprod. 1983; 8(Suppl. 1)144
   Google Scholar
• Lopes P., Mensier A. Ovarian cancer and assisted reproductive technology. Eur. J. Obstet. Gynecol. Reprodc. Biol. 1993; 51: 171–3
   Google Scholar
• Ben-Hur H., Dgani R., Lancet M., Katz Z., Nissim F., Rosenman D. Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. Acta Obstet. Gynecol. Scand. 1986; 65: 813–14
   Google Scholar
• Kulkarni R., McGarry J. M. Follicular stimulation and ovarian cancer. Br. Med. J. 1989; 299: 740
   Google Scholar
• Johannes J. B., Caro J. J., Hartz S. C., Marrs R. Adverse effects of ovulatory stimulants: a review. Assist. Reprod. Rev. 1993; 3: 68–74
   Google Scholar
• Bamford P. N., Steele S. J. Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report. Br. J. Obstet. Gynaecol. 1982; 89: 962–4
   Google Scholar
• Adas M., Menczer J. Massive hyperstimulation and borderline carcinoma of the ovary. Acta Obstet. Gynecol. Scand. 1982; 61: 261–3
   Google Scholar
• Carter M. E., Joyce D. N. Ovarian carcinoma in a patient hyperstimulated by gonadotrophin therapy for in vitro fertilization: a case report. J. In Vitro Fertil. Embryo Transfer 1987; 4: 126–8
   PubMedGoogle Scholar
• Died J. Ovulation and ovarian cancer. Lancet 1991; 338: 445
   Google Scholar
• Grimbizis G., Tarlatzis B. C., Bontis J., Miliaras D., Lagos S., Pournaropoulos F., Mantalenakis S. Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts. Hum. Reprod. 1995; 10: 520–3
   PubMedGoogle Scholar
• Lopes P., Julou V., Mensier A., Gamier J. M., Laborde O., Sagot P., L'Hermite A., Jean M., Barriere P. Cancer de l'ovaire et procréation médicalement assistée. Contracept. Fertil. Sexual. 1992; 20: 797–8
   Google Scholar
• Cohen J., Forman R., Harlap S., Johannisson E., Lunenfeld B., De Mouzon J., Pepperell R., Tarlatzis B., Templeton A. IFFS Expert Group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Hum. Reprod. 1993; 8: 996–1000
   PubMed Web of Science ®Google Scholar
• International Federation of Fertility Societies. Fertility drugs and ovarian cancer. Fertil. Steril. 1993; 60: 406–8
   Google Scholar
• Walters D. E., et al. Ovarian cancer and pregnancy: comment on a paper by Whittemore. Fertil. Steril. 1994; 61: 239–42
   Google Scholar
• Rossing M. A., Daling J. R., Weiss N. S., Moore D. E., Self S. G. Ovarian tumors in a cohort of infertile women. N. Engl. J. Med. 1994; 331: 771–6
   PubMed Web of Science ®Google Scholar
• Venn A., Watson L., Lumley J., Giles G., King C., Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995–1000
   PubMed Web of Science ®Google Scholar
• Willemsen W., Kruitwagen R., Bastiaans B., Hanselaar T., Rolland R. Ovarian stimulation and granulosa cell tumor. Lancet 1993; 341: 88
   Google Scholar